AHA expresses support for KEEP Telehealth Options Act

Jun 19, 2020 - 03:02 PM
computer-closeup-stethoscope-telehealth

The AHA today expressed support for the Knowing the Efficiency and Efficacy of Permanent (KEEP) Telehealth Options Act of 2020, which would allow the government to study the impact of telehealth during the COVID-19 pandemic and its expanded use. “We greatly appreciate the flexibilities implemented during the public health emergency, as they have allowed hospitals and health systems to care for patients in the comfort and safety of their own homes,” AHA wrote to the bill’s sponsors, Reps. Cynthia Axne, D-Iowa, and Troy Balderson, R-Ohio. In addition, AHA said that “additional data on telehealth uptake and usage is critical to help inform changes that will need to be addressed going forward to ensure patients can continue to access care through telehealth.”

Related News Articles

Headline
AHA responds to FDA request for information on AI-enabled medical devices
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
Permanent recall issued for Baxter ventilation system
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
CMS issues updated guidance on Medicare telehealth services 
The Centers for Medicare & Medicaid Services will retroactively pay claims for telehealth services provided during the government shutdown through Jan. 30…
Headline
CDC data shows rise in flu, COVID-19 cases across states 
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
Government shutdown ends as President Trump signs funding bill into law  
The 43-day government shutdown ended last night when President Trump signed a funding bill into law, hours after the House passed the measure by a 222-209 vote…
Headline
Recall issued for mislabeled potassium chloride
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…